Kazumasa Yoshida
No ORCID on file
· 1 paper in corpus
other
2025
Relugolix is an oral gonadotropin-releasing hormone receptor antagonist that suppresses sex steroid hormones and is approved as monotherapy for prostate cancer and as a fixed-dose combination with estradiol/norethindrone for the treatment o…